FDA approves 'breakthrough' Parkinson's treatment led by Cleveland Clinic doctor

Дата публикации: 28-09-2026 18:18:20

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical to those living with the disease.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA approves 'breakthrough' Parkinson's treatment led by Cleveland Clinic doctor	0	11.58	28-09-2026
2	STAT+: AbbVie wins FDA nod for Parkinson’s pill	0	12.5	28-09-2026
3	Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA	0	6.94	28-04-2026
4	European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease	0	7.44	26-09-2026
5	GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH	0	6.94	27-04-2026
6	STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare	0	7.35	29-09-2026
7	Blocking immune cells' path into the brain limits neurodegeneration	0	6.69	28-09-2026
8	Минздрав утвердил новый стандарт лечения депрессии у взрослых россиян	0	7.97	27-09-2026
9	STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years	0	4.11	29-09-2026
10	GLP-1 drugs may help sleep apnea, but CPAP remains best treatment: Study	0	8.6	27-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.58. Источник: fox8.com.